Health experts have worried for some time what might happen if a new form of gonorrhea develops that doesn’t respond to our ...

GSK's Blenrep approved in the U.K. for multiple myeloma after strong phase 3 data showing improved survival in DREAMM-7 and ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

Parts of DaVita's network were locked down by the attack, and the company has not yet provided a timeline for recovery. DaVita works with over 700 U.S. hospitals providing kidney dialysis. In pharma ...

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

British stocks tumbled as pharmaceutical shares slumped due to escalating tariffs between the U.S. and China. The FTSE 100 ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.

Now, after nearly three decades, the U.S. Food and Drug Administration (FDA) has approved Blujepa (gepotidacin), a new oral antibiotic from GSK, offering fresh hope for those struggling with ...

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.